COMBINATION OF HYPERTENSION AND DIABETES MELLITUS IN THE PRACTICE OF A FAMILY DOCTOR

Abstract

The relationship between arterial hypertension (AH) and type 2 diabetes mellitus (T2DM) has long been established based on the results of large-scale epidemiological and population-based studies. The number of patients with hypertension in combination with type 2 diabetes mellitus has been steadily increasing in recent years, increasing the risk of developing both macro- and microvascular complications, which progressively worsens their prognosis. LDL cholesterol is also a prognostic indicator of stroke risk in type 2 diabetes with a combination of several risk factors (hypertension and dyslipidemia), and early detection and early prescription of lipid-lowering therapy for the treatment or prevention of cardiovascular disease is especially important. In the presented clinical case in the patient on the background of rosuvastatin and fenofibrate administration there was a significant positive change in triglycerides from 3.8 mmol/l to 1.34 mmol/l. The problem of treatment effectiveness and improving the prognosis of patients with diabetes and hypertension remains complex. Success in treatment depends on compliance with the following provisions: the effectiveness of the antihypertensive properties of drugs (antihypertensive, hypoglycemic, hypolipidemic), the ability to achieve the target level of office blood pressure, SBP, since patients with diabetes mellitus with hypertension are mostly non-dippers; achieving and maintaining high adherence to therapy for many years.